Cambridge, Massachusetts Client: MIT Investment Management Company, Pfizer
Project Description
Designed for optimum flexibility, this 597,000-sf, two-building research and development campus provides new laboratories and offices for Pfizer and further enriches Kendall Square’s world-leading life science cluster.
With a program that includes street-level retail, offices, and laboratory/research facilities, the campus also provides parking for 650 cars on three levels below-grade.
Pfizer’s research facilities fill the seven-story South Building and most of the North Building, accommodating the company’s neuroscience, cardiovascular, metabolic, BTX, and endocrine disease research units.
Other tenants include CRISPR Therapeutics, LabCentral, KSQ Therapeutics, Bayer LifeHub Boston, Casebia Therapeutics, and Pfizer’s Centers for Therapeutic Innovation.
